Fortis Healthcare Ltd

  • BSE Code : 532843
  • NSE Symbol : FORTIS
  • ISIN : INE061F01013
  • Industry :HEALTHCARE

up-arrow 710.60 0.00(0.00%)

Open Price ()

708.00

Prev. Close ()

710.60

Volume (No’s)

2,332,242

Market Cap ()

53,647.33

Low Price ()

703.20

High Price ()

722.20

 

Book Closure

From Date To Date Announcement
20-May-2025 NA Fortis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 inter alia to consider and approve a) audited financial results of the Company for the quarter and financial year ended March 31 2025; and b) final dividend if any on the equity shares of the Company for the financial year ended March 31 2025. Pursuant to the provisions of Regulation 30, 33 and Regulation 51(2) and 52 read with Schedule III of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015 ('SEBI Listing Regulations') and the Master Circular issued by SEBI through circular number SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 as amended, please find attached the Outcome of Board meeting held on May 20, 2025. (As Per BSE Announcement Dated on :20.05.2025)
31-Mar-2025 NA Recommended final dividend of 1 per equity share (10% of face value of 10 /- each), for the financial year 2024-25, subject to approval of the members of the Company
20-Mar-2025 20-Mar-2025 In terms of Regulation 30 of SEBI (LODR) Regulations 2015 this is to inform you that the company is dispatching the postal ballot notice to its members today i.e. February 18 2025 for seeking their approval on the resolutions as appended in the enclosed Postal Ballot Notice. The relevant disclosure is attached. (As Per Bse Announcement Dated on 20.03.2025)
20-Mar-2025 NA Please Find enclosed disclosure for updates in policies.
19-Mar-2025 NA Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with SEBI Circular dated July 13, 2023, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. July 5, 2024 have, inter-alia, considered and recommended/ approved the following: a) Designated Dr. Prem Kumar Nair (a Non- Executive Director) as the Vice-Chairman of the Board of the Company. b) Recommended re-appointment of Dr. Ashutosh Raghuvanshi as Managing Director (designated as Managing Director & Chief Executive Officer) for a further period of two years effective from March 19, 2025, not liable to retire by rotation; and The detailed disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 is enclosed as Annexure-A

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew